Finding 1079017 (2023-005)

Significant Deficiency
Requirement
ABCH
Questioned Costs
-
Year
2023
Accepted
2024-10-12
Audit: 324580
Organization: Okanogan Behavioral Healthcare (WA)

AI Summary

  • Core Issue: Significant deficiency in internal controls over compliance, specifically related to payroll expenditures being based on incorrect pay periods.
  • Impacted Requirements: Internal controls for cash management and allowable costs were not properly followed, leading to inaccuracies in reimbursement claims.
  • Recommended Follow-Up: Ensure all grant billings are reviewed and approved by an independent individual, including a thorough check of supporting documentation for accuracy.

Finding Text

Federal Agency: U.S. Department of Health and Human Services Federal Program Name: Substance Abuse Prevention and Treatment Block Grant (SABG); SOR Recovery Support Services Assistance Listing Number: 93.959 and 93.788 Federal Award Identification Number and Year: K6103.01 – 2023, K6479 - 2023 Pass-Through Agency: Washington State Health Care Authority Pass-Through Number(s): K6103.01, K6479 Award Period: July 1, 2022 – June 30, 2023; September 29, 2022 – September 28, 2023 Type of Finding: Significant Deficiency in Internal Control over Compliance – Allowable Costs and Activities,Cash Management, and Period of Performance; Other Matters Criteria or specific requirement: Proper internal controls over cash management and indirect costs include the review and approval of grant draws prior to submission to the granting agency, to ensure accuracy of expenditures. Condition: The payroll expenditures included on the February 2023 reimbursement request were determined based on February 2022 payroll activity, rather than the February 2023 payroll activity. Questioned costs: None. Context: Of the six reimbursement requests tested for SABG and five for SOR, noted one for each grant (same time period) in which incorrect pay periods were used to determine the amount of reimbursement to claim. For the payroll transactions selected for testing, two out of 10 for SABG and two out of eight for SOR were for payroll costs incurred in February 2022 and were not within the grant period. Cause: Payroll activity for the wrong year was used to determine the amount to claim for expense reimbursement. Effect: Payroll expenditures were overcharged to the grant. Repeat finding: Not a repeat finding. Recommendation: We recommend all grant billings are reviewed and approved by an individual independent of the preparation process and that this review includes reviewing supporting documentation for the expenditures being claimed to ensure the amount charged to the grant is accurate. Views of responsible officials: There is no disagreement with the audit finding

Categories

Cash Management Allowable Costs / Cost Principles Period of Performance Significant Deficiency

Other Findings in this Audit

  • 502571 2023-001
    Significant Deficiency Repeat
  • 502572 2023-002
    Significant Deficiency
  • 502573 2023-003
    Significant Deficiency
  • 502574 2023-004
    Significant Deficiency
  • 502575 2023-005
    Significant Deficiency
  • 502576 2023-006
    Material Weakness
  • 502577 2023-007
    Significant Deficiency
  • 502578 2023-008
    Material Weakness
  • 502579 2023-002
    Significant Deficiency
  • 502580 2023-005
    Significant Deficiency
  • 502581 2023-007
    Significant Deficiency
  • 502582 2023-002
    Significant Deficiency
  • 502583 2023-006
    Material Weakness
  • 502584 2023-002
    Significant Deficiency
  • 502585 2023-007
    Significant Deficiency
  • 502586 2023-008
    Material Weakness
  • 1079013 2023-001
    Significant Deficiency Repeat
  • 1079014 2023-002
    Significant Deficiency
  • 1079015 2023-003
    Significant Deficiency
  • 1079016 2023-004
    Significant Deficiency
  • 1079018 2023-006
    Material Weakness
  • 1079019 2023-007
    Significant Deficiency
  • 1079020 2023-008
    Material Weakness
  • 1079021 2023-002
    Significant Deficiency
  • 1079022 2023-005
    Significant Deficiency
  • 1079023 2023-007
    Significant Deficiency
  • 1079024 2023-002
    Significant Deficiency
  • 1079025 2023-006
    Material Weakness
  • 1079026 2023-002
    Significant Deficiency
  • 1079027 2023-007
    Significant Deficiency
  • 1079028 2023-008
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $407,550
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $130,992
14.267 Continuum of Care Program $75,071
93.665 Emergency Grants to Address Mental and Substance Use Disorders During Covid-19 $60,429
93.958 Block Grants for Community Mental Health Services $42,000
93.959 Block Grants for Prevention and Treatment of Substance Abuse $36,000